BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Roesch EA, Nichols DP, Chmiel JF. (2018) Inflammation in cystic fibrosis: An update. Pediatric Pulmonology |
| Nichols DP, Chmiel JF. (2015) Inflammation and its genesis in cystic fibrosis. Pediatric Pulmonology. 50: S39-56 |
| Taylor-Cousar JL, Wiley C, Felton LA, et al. (2015) Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 228-36 |
| Taylor-Cousar JL, Von Kessel KA, Young R, et al. (2010) Potential of anti-inflammatory treatment for cystic fibrosis lung disease. Journal of Inflammation Research. 3: 61-74 |
| Nichols DP, Ziady AG, Shank SL, et al. (2009) The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. American Journal of Physiology. Lung Cellular and Molecular Physiology. 297: L828-36 |
| Perez A, van Heeckeren AM, Nichols D, et al. (2008) Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium. American Journal of Physiology. Lung Cellular and Molecular Physiology. 295: L303-13 |
| Nichols DP, Konstan MW, Chmiel JF. (2008) Anti-inflammatory therapies for cystic fibrosis-related lung disease. Clinical Reviews in Allergy & Immunology. 35: 135-53 |
| Nichols D, Chmiel J, Berger M. (2008) Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clinical Reviews in Allergy & Immunology. 34: 146-62 |